Phase 2 Study of MGCD265 in Patients With Non-Small Cell Lung Cancer With Activating Genetic Alterations in MET

PHASE2CompletedINTERVENTIONAL
Enrollment

68

Participants

Timeline

Start Date

October 31, 2015

Primary Completion Date

April 30, 2018

Study Completion Date

January 31, 2019

Conditions
Non-Small Cell Lung Cancer
Interventions
DRUG

MGCD265

MGCD265 is a small molecule multi-targeted receptor tyrosine kinase inhibitor

Trial Locations (94)

807

Kaohsiung Medical University Hospital, Kaohsiung City

970

Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Hualien City

1121

Országos Korányi TBC és Pulmonológiai Intézet, Budapest

1122

Országos Onkológiai Intézet, Budapest

1125

Semmelweis Egyetem, Budapest

2065

Royal North Shore Hospital, Saint Leonards

2139

Concord Repatriation General Hospital, Concord

2217

Saint George Hospital, Kogarah

2485

The Tweed Hospital, Tweed Heads

2800

Szent Borbála Kórház, Tatabánya

3084

Austin Health, Heidelberg

3165

Monash Cancer Centre, Clayton

Monash Health, Clayton

4102

Princess Alexandra Hospital, Woolloongabba

5042

Flinders Medical Centre, Bedford Park

7000

Royal Hobart Hospital, Hobart

10021

Clinical Research Alliance, New York

10126

Azienda Ospedaliera Città della Salute e della Scienza di Torino, Torino

10467

Montefiore Medical Center, The Bronx

11217

Taipei Veterans General Hospital, Taipei

11430

Queens Cancer Center, Jamaica

18840

Guthrie Cancer Center, Sayre

19111

Fox Chase Cancer Center, Philadelphia

20007

Georgetown University Medical Center, Washington D.C.

20132

IRCCS Ospedale San Raffaele, Milan

Istituto Europeo di Oncologia Milano, Milan

Ospedale San Raffaele, Milan

29100

Azienda Unità Sanitaria Locale di Piacenza-Ospedale Guglielmo da Saliceto, Piacenza

29615

Greenville Health System, Greenville

33028

Memorial Hospital West, Pembroke Pines

33140

Mount Sinai Medical Center, Miami Beach

33486

Boca Raton Regional Hospital - Eugene M. & Christine E. Lynn Cancer Institute, Boca Raton

33705

Florida Cancer Specialists, St. Petersburg

33916

Florida Cancer Specialists, Fort Myers

35294

University of Alabama at Birmingham, Birmingham

35805

Clearview Cancer Institute, Huntsville

37203

Sarah Cannon Research Institute, Nashville

40245

Kentuckyone Health Cancer and Blood Speacialists, Louisville

40503

Lexington Oncology Associates, LLC, Lexington

40705

Taichung Veterans General Hospital, Taichung

44106

University Hospitals of Cleveland, Cleveland

46526

Goshen Center for Cancer Care, Goshen

48121

Azienda Unita Sanitaria Locale di Ravenna, Ravenna

48202

Henry Ford Health System, Detroit

50139

Azienda Ospedaliero-Universitaria Careggi, Florence

50401

Mercy Cancer Center, Mason City

55041

Ospedale Unico Versilia, Lucca

55455

University of Minnesota Masonic Cancer Center, Minneapolis

60153

Loyola University Medical Center, Maywood

60201

NorthShore University HealthSystem, Evanston

60611

Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago

60612

Rush University Medical Center, Chicago

63110

Washington University, St Louis

70403

National Cheng Kung University, Tainan City

71301

Christus Saint Frances Cabrini Hospital, Alexandria

72401

Fowler Family Center for Cancer Care, Jonesboro

73657

Chi Mei Hospital Liouying, Tainan City

77030

MD Anderson Cancer Center, Houston

81501

St. Mary's Regional Cancer Center, Grand Junction

87102

The University of New Mexico Cancer Research and Treatment Center, Albuquerque

90603

Innovative Clinical Reseach Institute, Whittier

91505

Providence Saint Joseph Medical Center, Burbank

92121

University of California San Diego, La Jolla

92354

Loma Linda University Medical Center, Loma Linda

94143

University of California, San Francisco, San Francisco

98109

Seattle Cancer Care Alliance, Seattle

752010

Mary Crowley Cancer Research Centers, Dallas

92835-3825

Saint Joseph Heritage Healthcare, Fullerton

06360

Eastern Connecticut Hematology and Oncology Associates, Norwich

33442-7753

Sylvester Comprehensive Cancer Center, Deerfield Beach

40422-2534

Oncology-Hematology Associates, PA, Danville

02111

Tufts Medical Center, Boston

02215

Beth Israel Deaconess Medical Center, Boston

Dana Farber Cancer Institute, Boston

07601

Hackensack University Medical Center, Hackensack

H2W 1S6

McGill University Health Centre, Montreal

60-693

Med Polonia Sp. z o.o., Poznan

80-952

Uniwersyteckie Centrum Kliniczne, Gdansk

10-357

Samodzielny Publiczny Zespól Gruzlicy i Chorób Pluc w Olsztynie, Olsztyn

410-769

National Cancer Center, Goyang-si

463-707

Seoul National University Bundang Hospital, Seongnam-si

442-723

Saint Vincent Hospital, Suwon

The Catholic University of Korea Saint Vincent's Hospital, Suwon

361-271

Chungbuk National University Hospital, Cheongju-si

700-712

Keimyung University Dongsan Medical Center, Daegu

110-744

Seoul National University Hospital, Seoul

120-752

Severance Hospital, Yonsei University Health System, Seoul

134-791

Veterans Health Service Medical Center, Seoul

135-710

Samsung Medical Center, Seoul

138-736

Asan Medical Center, Seoul

BS10 5NB

North Bristol NHS Trust, Westbury on Trym, Bristol

NW1 2PQ

University College London Hospitals NHS Foundation Trust, London

HA6 2RN

East and North Hertordshire NHS Trust, Northwood

NW3 2QG

Royal Free London NHS Foundation Trust, London

Sponsors
All Listed Sponsors
lead

Mirati Therapeutics Inc.

INDUSTRY

NCT02544633 - Phase 2 Study of MGCD265 in Patients With Non-Small Cell Lung Cancer With Activating Genetic Alterations in MET | Biotech Hunter | Biotech Hunter